Search research articles
Contact Us
Filters
Showing results (141-150 of 164) with videos related to
Page
of 17
Sort By:
JTO Clinical and Research Reports
|
September 9, 2022
A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With <i>EGFR</i>-Mutant NSCLC
Kenji Morimoto, Ryo Sawada, Tadaaki Yamada, et al.
Cancer Science
|
October 27, 2021
Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L
Shinya Sakata, Kohei Otsubo, Hisako Yoshida, et al.
European Journal of Pharmacology
|
November 9, 2023
Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models
Genzui Setsu, Megumi Goto, Kentaro Ito, et al.
Clinical Lung Cancer
|
June 21, 2023
Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial
Kimio Yonesaka, Hidetoshi Hayashi, Atsushi Nakamura, et al.
JTO Clinical and Research Reports
|
December 4, 2023
A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)
Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 22, 2021
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)
Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, et al.
Respiratory Investigation
|
August 2, 2025
Pathogen detection by multiplex PCR: A comparative study of pneumonia panel, bacterial culture, and respiratory panel in Japanese patients
Osamu Hataji, Kengo Ushiro, Remi Inoue, et al.
Translational Lung Cancer Research
|
June 13, 2022
An exploration of the clinical progression models of osimertinib in the treatment of advanced EGFR-mutant non-small cell lung cancer
Yue Shi, Yingying Jiang, Banzhou Pan, et al.
Scientific Reports
|
September 7, 2023
Close-to-lesion transbronchial biopsy: a novel technique to improve suitability of specimens for genetic testing in patients with peripheral pulmonary lesions
Yoichi Nishii, Tadashi Sakaguchi, Seiya Esumi, et al.
Respiration; International Review of Thoracic Diseases
|
July 2, 2025
Suitability of Specimens from Pleural Dissemination of Non-Small Cell Lung Cancer for Genetic Testing Using Forceps and Cryobiopsy
Yoichi Nishii, Tadashi Sakaguchi, Seiya Esumi, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 164) with videos related to
Sort By:
Page
of 17
JTO Clinical and Research Reports
|
September 9, 2022
A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With <i>EGFR</i>-Mutant NSCLC
Kenji Morimoto, Ryo Sawada, Tadaaki Yamada, et al.
Cancer Science
|
October 27, 2021
Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L
Shinya Sakata, Kohei Otsubo, Hisako Yoshida, et al.
European Journal of Pharmacology
|
November 9, 2023
Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models
Genzui Setsu, Megumi Goto, Kentaro Ito, et al.
Clinical Lung Cancer
|
June 21, 2023
Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial
Kimio Yonesaka, Hidetoshi Hayashi, Atsushi Nakamura, et al.
JTO Clinical and Research Reports
|
December 4, 2023
A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)
Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 22, 2021
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)
Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, et al.
Respiratory Investigation
|
August 2, 2025
Pathogen detection by multiplex PCR: A comparative study of pneumonia panel, bacterial culture, and respiratory panel in Japanese patients
Osamu Hataji, Kengo Ushiro, Remi Inoue, et al.
Translational Lung Cancer Research
|
June 13, 2022
An exploration of the clinical progression models of osimertinib in the treatment of advanced EGFR-mutant non-small cell lung cancer
Yue Shi, Yingying Jiang, Banzhou Pan, et al.
Scientific Reports
|
September 7, 2023
Close-to-lesion transbronchial biopsy: a novel technique to improve suitability of specimens for genetic testing in patients with peripheral pulmonary lesions
Yoichi Nishii, Tadashi Sakaguchi, Seiya Esumi, et al.
Respiration; International Review of Thoracic Diseases
|
July 2, 2025
Suitability of Specimens from Pleural Dissemination of Non-Small Cell Lung Cancer for Genetic Testing Using Forceps and Cryobiopsy
Yoichi Nishii, Tadashi Sakaguchi, Seiya Esumi, et al.
Page
of 17